Premier, Inc.’s PINC AI™ Applied Sciences (PAS) and TFS HealthScience Will Partner to Revolutionize Clinical Trials
December 12 2023 - 7:00AM
Business Wire
- Aims to enhance global trial recruitment and operations, reach
underrepresented populations, help lower costs and increase speed
to commercialization.
- Will leverage real-world data and evidence (RWD/RWE) and
artificial intelligence (AI)-enabled technology to support clinical
and operational transformation at scale.
Premier, Inc.’s PINC AI™ Applied Sciences (PAS) and TFS
HealthScience are announcing a landmark collaboration to accelerate
global clinical trials and research innovation, improve patient
outcomes and reduce health disparities.
The partnership will combine TFS’ capabilities, systems and
clinical development expertise with PAS’ AI-enabled technology and
comprehensive healthcare database. The collaboration will help
expedite site and patient enrollment, reduce trial costs,
accelerate the journey to commercialization, and ensure equitable
access to groundbreaking medical solutions across diverse patient
populations.
Eighty percent of all trials face premature termination or
significant delays due to recruitment challenges – and marginalized
populations, including Black and Hispanic individuals, remain
historically underrepresented.
Leveraging comprehensive real-world data (RWD) and AI-enabled
tools from PAS, TFS will gain enhanced capabilities to assess site
suitability on a larger scale and focus on appropriate patient
populations, investigator availability, therapeutic areas expertise
and historical clinical trial performance metrics. This data-driven
approach has already enabled PAS-supported trials to improve
recruitment by 1800 percent and triple enrollment compared to
baseline projections – significantly reducing enrollment periods
and costs.
“The PAS-TFS partnership will bring the advantages of
high-quality RWD/RWE and the benefits of AI-enabled technology to
trial sponsors, investigators and life sciences entities
worldwide,” said Denise Juliano, Group Vice President of Life
Sciences at Premier. “Our combined strengths will help enhance data
analysis, provide trial designs that are both diverse and
equitable, advance early disease detection and reduce disparities
with aim to advance global health equity.”
Dr. Bassem Saleh, Chief Executive Officer at TFS, emphasizes the
global impact of the collaboration: “Technology, including AI, will
help accelerate clinical research through efficient clinical trial
designs, synthetic arms and faster patient identification and
recruitment. Working with PAS will open new avenues for innovative
clinical trials in Europe and the U.S., benefiting biotech, pharma
and medical device companies across various phases and RWE studies
and ensuring more inclusive and patient-centric research.”
The PAS-TFS partnership has plans for implementation in multiple
studies per year across all therapeutic areas and indications.
Data-driven designs will enable sponsors to integrate decentralized
approaches with an emphasis on remote health and in-home patient
monitoring options using mobile apps and wearables, helping lower
overall trial costs.
This strategic collaboration is set to further enable TFS’s
expansion in the U.S. and enhance PINC AI’s global influence,
especially in the European market, leveraging TFS’s extensive
network. By uniting their capabilities, PAS and TFS are committed
to driving forward innovation in clinical research and offering
efficient solutions that prioritize patient health outcomes and
equity.
About TFS HealthScience
TFS HealthScience is a global clinical Contract Research
Organization (CRO) that supports biotechnology and pharmaceutical
companies throughout their entire clinical development journey. In
partnership with customers, we build solution-driven teams working
for a healthier future. Bringing together nearly 800 professionals,
TFS delivers tailored clinical research services in more than 40
countries and supports customers with comprehensive solutions
through two strong business models: Clinical Development Services
(CDS), which provides full-service support at all stages of the
clinical development process and Strategic Resourcing Solutions
(SRS), which offers expert insourcing, targeted recruitment, and
strategic workforce management solutions.
About PINC AI™ Applied Sciences (PAS)
PAS is a trusted leader in accelerating healthcare improvement
through services, data and scalable solutions, spanning the
continuum of care and enabling sustainable innovation and rigorous
research. These services and RWD are valuable resources for the
pharmaceutical, device and diagnostic industries, academia, federal
and national healthcare agencies, as well as hospitals and health
systems. Since 2000, PAS researchers have produced more than 1,000
publications which appear in 264 scholarly, peer-reviewed journals,
covering a wide variety of topics, and conduct population-based
analyses of drugs, devices, treatments, disease states,
epidemiology, resource utilization, healthcare economics and
clinical outcomes.
About the PINC AI™ Platform
PINC AI™ is the technology and services platform of Premier,
Inc. (NASDAQ: PINC). With more than 20 years’ worth of cost,
quality and operational data gleaned from 45 percent of U.S.
hospital discharges, 2.7 billion hospital outpatient and clinic
encounters and 177 million physician office visits, the PINC AI™
platform provides actionable intelligence to help improve outcomes,
support improved financial performance and enable success in new,
alternative payment models. PINC AI™ incorporates the 100 Top
Hospitals ® Program that inspires hospital and health system
leaders to pursue higher performance and deliver added value to
their patients and communities. PINC AI™ offerings rely on advanced
analytics to identify improvement opportunities; support
award-winning Strategic Collaboratives for value-based care,
maternal and infant health, workforce innovation, and health
equity; and consulting services for clinical and operational
design, and workflow solutions to hardwire sustainable change. The
PINC AI™ platform is also the data engine powering Premier’s newest
brands – Remitra® and Contigo Health®. With a leading network of
provider organizations, the PINC AI™ platform accelerates ingenuity
and serves as a large-scale innovation catalyst in healthcare. PINC
AI™ offerings and capabilities can be followed on X (formerly
Twitter) and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231212690650/en/
Public_Relations@premierinc.com
Premier (NASDAQ:PINC)
Historical Stock Chart
From May 2024 to Jun 2024
Premier (NASDAQ:PINC)
Historical Stock Chart
From Jun 2023 to Jun 2024